Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
Open | $1.21 |
Close | $1.22 |
Volume / Avg. | 5.63K / 50.54K |
Day Range | 1.20 - 1.23 |
52 Wk Range | 0.89 - 2.12 |
Market Cap | $34.34M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclo Therapeutics (NASDAQ:CYTH) through any online brokerage.
Other companies in Cyclo Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
There is no analysis for Cyclo Therapeutics.
Cyclo Therapeutics has a consensus price target of $3.20.
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $1.2 last updated June 26, 2024 at 4:38 PM EDT.
There are no upcoming dividends for Cyclo Therapeutics.
Cyclo Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Cyclo Therapeutics.
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.